MCLAUGHLIN JOHN PETER 4
4 · PDL BIOPHARMA, INC. · Filed Aug 24, 2020
Insider Transaction Report
Form 4
MCLAUGHLIN JOHN PETER
Director
Transactions
- Award
Common stock
2020-08-19+25,826→ 527,934 total - Award
Stock Option (right to buy)
2020-08-19$3.63/sh+118,671$430,776→ 118,671 totalExercise: $3.63From: 2021-08-19Exp: 2030-08-19→ Common stock (118,671 underlying)
Footnotes (2)
- [F1]The restricted stock will vest on the one year anniversary of the grant date, subject to acceleration of vesting upon a change in control or the Company filing a certificate of dissolution with the state of Delaware; provided that the recipient's continuous service has not terminated prior to such date.
- [F2]The stock options will vest on the one year anniversary of the grant date, subject to acceleration of vesting upon a change in control or the Company filing a certificate of dissolution with the state of Delaware; provided that the recipient's continuous service has not terminated prior to such date.